MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in MAIA Biotechnology, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +6 vs. Q1 2023
- Shares held
- 321.9K
- +250.4K (+350.1%) vs. Q1 2023
- Total value
- $709.1K
- +$462.4K (+187.4%) vs. Q1 2023
- New holders
- 7
- 4 more added
- Sold out
- 1
- 1 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MAIA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $19.4M |
| Q1 2026 | 33 | $18.4M |
| Q4 2025 | 26 | $4.09M |
| Q3 2025 | 19 | $3.49M |
| Q2 2025 | 20 | $3.95M |
| Q1 2025 | 20 | $2.26M |
| Q4 2024 | 20 | $2.75M |
| Q3 2024 | 17 | $4.15M |
| Q2 2024 | 21 | $6.09M |
| Q1 2024 | 20 | $1.50M |
| Q4 2023 | 22 | $957.8K |
| Q3 2023 | 14 | $699.6K |
| Q2 2023 | 12 | $709.1K |
| Q1 2023 | 6 | $246.7K |
| Q4 2022 | 6 | $1.04M |
| Q3 2022 | 9 | $763.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding MAIA Biotechnology, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 93,500 | $205.7K | 0.00% | +93,500 | New |
| Centric Wealth Management | 64,456 | $142.4K | 0.06% | +24,250+60.3% | Added |
| Lynwood Capital Management Inc. | 35,000 | $77.0K | 0.10% | +35,000 | New |
| Geode Capital Management, LLC | 33,987 | $74.8K | 0.00% | +33,987 | New |
| Bridgeway Capital Management, LLC | 26,600 | $58.5K | 0.00% | +26,600 | New |
| Citadel Advisors LLC | 23,387 | $51.5K | 0.00% | +23,387 | New |
| Naviter Wealth, LLC | 22,168 | $48.8K | 0.01% | +22,168 | New |
| Renaissance Technologies LLC | 10,800 | $24.0K | 0.00% | −9,850−47.7% | Reduced |
| BlackRock Inc. | 8,017 | $17.6K | 0.00% | +4,011+100.1% | Added |
| Tower Research Capital LLC (TRC) | 3,962 | $8.72K | 0.00% | +1,256+46.4% | Added |
| Wells Fargo & Company | 34 | $75 | 0.00% | +20+142.9% | Added |
| Royal Bank of Canada | 27 | $0 | 0.00% | +27 | New |
| UBS Group AG | 0 | $0 | 0.00% | −3,949−100.0% | Sold out |